Yearly Archives: 2004

Company Targets Coma Patients with Compound

Company Targets Coma Patients with Compound

NeuroHealing Commences Clinical Trial of NH001 for Coma Patients

Newton, Mass., December 8, 2004 — E-Worldwire NeuroHealing Pharmaceuticals Inc., a private, early stage pharmaceutical company, today announced the start of a clinical trial of its first product candidate NH001 for the treatment of patients in a vegetative or minimally conscious state. This is a multi-center, open-label, Phase IIa study to evaluate the safety and…

Twilight Zone

Twilight Zone

NeuroHealing Pharmaceuticals Focuses on Coma Recovery Treatment

NeuroHealing Pharmaceuticals Focuses on Coma Recovery Treatment

Harvard Biotechnology Club Awards NeuroHealing Pharmaceuticals First Prize in Business Plan Competition

Boston, June 14, 2004 – PRNewswire In the 2004 Biotechnology Business Plan Competition organized by the GSAS Harvard Biotechnology Club, NeuroHealing Pharmaceuticals Inc., a pharmaceutical company focused on the development of treatments for the neuro-rehabilitation market, was awarded first prize by the panel of judges comprised of members of leading venture capital firms. At the…

Selected Start-Ups

Selected Start-Ups

Neurohealing Pharmaceuticals – FIRST PLACE

Neurohealing Pharmaceuticals – FIRST PLACE